Design and synthesis of new N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents.

[1]  Y. Wu,et al.  Inhibitory effects of 16-hydroxycleroda-3,13(14)E-dien-15-oic acid on superoxide anion and elastase release in human neutrophils through multiple mechanisms. , 2008, European journal of pharmacology.

[2]  T. Hwang,et al.  Inhibition of superoxide anion and elastase release in human neutrophils by 3′‐isopropoxychalcone via a cAMP‐dependent pathway , 2006, British journal of pharmacology.

[3]  J. Vinten-johansen.  Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. , 2004, Cardiovascular research.

[4]  M. Uchiba,et al.  Ranitidine reduces ischemia/reperfusion-induced liver injury in rats by inhibiting neutrophil activation. , 2002, The Journal of pharmacology and experimental therapeutics.

[5]  N. Sakurai,et al.  Aurantiamide Acetate, a Selective Cathepsin Inhibitor, Produced by Aspergillus penicilloides , 2001, Bioscience, biotechnology, and biochemistry.

[6]  K. C. Lee,et al.  NPC-14686, a novel anti-inflammatory agent, increased intracellular Ca(2+) concentrations in MDCK renal tubular cells. , 2000, International journal of immunopharmacology.

[7]  P. Rieu,et al.  Neutrophils: Molecules, Functions and Pathophysiological Aspects , 2000, Laboratory Investigation.

[8]  S. Kuo,et al.  Constituents and bioactive principles of Polygonum chinensis. , 1998, Phytochemistry.

[9]  L. Stanton,et al.  Fluorenylalkanoic and benzoic acids as novel inhibitors of cell adhesion processes in leukocytes. , 1995, Journal of medicinal chemistry.

[10]  J I Gallin,et al.  Current concepts: immunology. Neutrophils in human diseases. , 1987, The New England journal of medicine.